Sinopec Shanghai Petrochemical Company Limited

SHSC:338 Stock Report

Market Cap: HK$27.2b

Sinopec Shanghai Petrochemical Valuation

Is 338 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

3/6

Valuation Score 3/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 338 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: 338 (HK$1.14) is trading above our estimate of fair value (HK$0.17)

Significantly Below Fair Value: 338 is trading above our estimate of fair value.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for 338?

Key metric: As 338 is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for 338. This is calculated by dividing 338's market cap by their current revenue.
What is 338's PS Ratio?
PS Ratio0.1x
SalesCN¥89.15b
Market CapCN¥25.28b

Price to Sales Ratio vs Peers

How does 338's PS Ratio compare to its peers?

The above table shows the PS ratio for 338 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PSEstimated GrowthMarket Cap
Peer Average0.3x
1907 China Risun Group
0.2x6.4%HK$13.6b
746 Lee & Man Chemical
0.8xn/aHK$3.0b
2198 China Sanjiang Fine Chemicals
0.1xn/aHK$2.0b
2881 Wuhan Youji Holdings
0.1xn/aHK$489.8m
338 Sinopec Shanghai Petrochemical
0.1x-3.1%HK$27.2b

Price-To-Sales vs Peers: 338 is good value based on its Price-To-Sales Ratio (0.1x) compared to the peer average (0.3x).


Price to Sales Ratio vs Industry

How does 338's PS Ratio compare vs other companies in the HK Chemicals Industry?

2 CompaniesPrice / SalesEstimated GrowthMarket Cap
827 Ko Yo Chemical (Group)
0.08xn/aUS$31.76m
1047 Ngai Hing Hong
0.09xn/aUS$15.18m
No more companies available in this PS range
338 0.1xIndustry Avg. 0.4xNo. of Companies7PS00.40.81.21.62+
2 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Sales vs Industry: 338 is good value based on its Price-To-Sales Ratio (0.1x) compared to the Hong Kong Chemicals industry average (0.4x).


Price to Sales Ratio vs Fair Ratio

What is 338's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

338 PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio0.1x
Fair PS Ratio0.3x

Price-To-Sales vs Fair Ratio: 338 is good value based on its Price-To-Sales Ratio (0.1x) compared to the estimated Fair Price-To-Sales Ratio (0.3x).


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst 338 forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentHK$1.14
HK$1.24
+8.6%
20.1%HK$1.74HK$1.10n/a5
Nov ’25HK$1.21
HK$1.24
+2.3%
20.1%HK$1.74HK$1.10n/a5
Oct ’25HK$1.20
HK$1.25
+4.6%
21.7%HK$1.80HK$1.10n/a5
Sep ’25HK$1.04
HK$1.27
+22.5%
20.5%HK$1.79HK$1.10n/a5
Aug ’25HK$1.08
HK$1.31
+21.0%
23.4%HK$1.91HK$1.09n/a5
Jul ’25HK$1.10
HK$1.45
+32.2%
29.6%HK$2.19HK$1.10n/a6
Jun ’25HK$1.13
HK$1.46
+28.8%
29.7%HK$2.19HK$1.10n/a6
May ’25HK$1.11
HK$1.44
+30.0%
28.1%HK$2.20HK$1.09n/a7
Apr ’25HK$1.03
HK$1.44
+40.0%
28.0%HK$2.19HK$1.09n/a7
Mar ’25HK$1.12
HK$1.52
+35.5%
28.5%HK$2.20HK$1.09n/a6
Feb ’25HK$1.05
HK$1.52
+44.9%
28.4%HK$2.20HK$1.09n/a6
Jan ’25HK$1.13
HK$1.52
+34.6%
28.4%HK$2.20HK$1.09n/a6
Dec ’24HK$1.12
HK$1.63
+45.6%
25.7%HK$2.21HK$1.22n/a5
Nov ’24HK$1.06
HK$1.59
+50.3%
25.8%HK$2.16HK$1.17HK$1.215
Oct ’24HK$1.11
HK$1.59
+43.5%
24.4%HK$2.17HK$1.18HK$1.206
Sep ’24HK$1.10
HK$1.54
+40.2%
25.1%HK$2.18HK$1.18HK$1.047
Aug ’24HK$1.19
HK$1.62
+36.2%
23.3%HK$2.20HK$1.19HK$1.087
Jul ’24HK$1.23
HK$1.64
+33.3%
20.0%HK$2.19HK$1.28HK$1.107
Jun ’24HK$1.26
HK$1.65
+31.3%
20.6%HK$2.22HK$1.30HK$1.137
May ’24HK$1.37
HK$1.63
+18.8%
26.6%HK$2.27HK$0.90HK$1.117
Apr ’24HK$1.37
HK$1.66
+20.9%
26.5%HK$2.30HK$0.92HK$1.037
Mar ’24HK$1.37
HK$1.66
+20.8%
24.0%HK$2.18HK$0.90HK$1.127
Feb ’24HK$1.46
HK$1.64
+12.1%
29.5%HK$2.23HK$0.91HK$1.057
Jan ’24HK$1.32
HK$1.59
+20.2%
29.7%HK$2.15HK$0.88HK$1.137
Dec ’23HK$1.25
HK$1.51
+20.8%
30.9%HK$2.10HK$0.86HK$1.127
Nov ’23HK$1.05
HK$1.51
+43.8%
30.9%HK$2.10HK$0.86HK$1.067

Analyst Forecast: Target price is less than 20% higher than the current share price.


Discover undervalued companies